Biotech news
Europe
The company’s rivals convinced an EPO appeals board to revoke a patent that had been used in litigation against them over Comirnaty. 30 April 2026
Americas
Pharma group strikes an all-cash transaction, combining a portfolio expansion with a contingent payment linked to a dispute over a $5 billion drug 28 April 2026
Americas
BioNTech’s former rival—now part of its company—is seeking to assert its mRNA portfolio against Moderna in a new suit over modifications to the highly fought-over molecule. 28 April 2026
Americas
Decision underscores a growing deference to parallel rulings and tighter control over duplicate patent challenges. 22 April 2026
Americas
A ruling that invalidated three of Teva's headache treatment patents has been thrown out, sending a long-running case back to the lower court. 17 April 2026
Americas
The Cambridge biotech is accused of infringing six patents covering technologies used to target drug-resistant cancer mutations. 16 April 2026
Americas
The 2026 panel has been chosen. With judges from Amgen, Pfizer, Eli Lilly, Takeda, Regeneron and law firms such as White & Case and Arnold & Porter, here’s who will be deciding this year’s winners. 10 April 2026
Biotech
The acquisition of Munich-based biotech gives Gilead ownership of proprietary ADCs tech at a time when pharma and biotech companies are racing to secure next-generation cancer treatments. 8 April 2026
Biotech
On World Health Day 2026, despite data trending in the right direction, systemic barriers continue to limit female inventors—and women's health is suffering. 7 April 2026
Europe
A Lisbon judge rejects a bid to strike out the case over a drafting issue, offering insight into the court’s high bar for early dismissal. 2 April 2026